DiabetesBe a Leader in Research and Practice

Explore all the ways we support research and practice - including the recently published Hypoglycemia Blueprint, the Diabetes Technology Practice Guideline, and research on reducing cardiovascular disease in diabetes.

Urine Metabolites May Help Predict Which Obese Teens Will Develop Diabetes
April 4, 2017 | Researchers have discovered a unique metabolic “signature” in the urine of diabetic, obese black teenagers that they say may become a way to predict the development of type 2 diabetes…

Children at High Risk of Diabetes Should be Screened by HbA1C and Oral Glucose Tolerance Tests
April 4, 2017 | Doctors should add an oral glucose tolerance test (OGTT) to their hemoglobin A1C (HbA1C) when they screen high-risk children for prediabetes and diabetes, new research…

Diabetes Control is More Difficult for Night Shift Workers
April 3, 2017 | People with type 2 diabetes have poorer control over their blood glucose levels when they work the night shift compared with those who work in the daytime…

In the US Military, White Kids and Officers' Kids More Likely to Use Diabetes Control Technology
April 3, 2017 | Even with equal access to healthcare in the United States military, significant disparities in caring for children with type 1 diabetes still exist…

Artificial Pancreas Improves Blood Sugar Control in Young Kids
April 3, 2017 | An artificial pancreas, which delivers insulin in an automated way to individuals with type 1 diabetes, appears to be safe and effective for use in children ages 5 to 8…

Program Equips Rural Primary Care Providers to Manage Complex Diabetes
April 3, 2017 | Primary care providers (PCPs) and community health workers in rural areas of New Mexico gained confidence in in their ability to manage patients with complex diabetes…

New Simple Tool Can Help Identify People at High Risk for Prediabetes
April 3, 2017 | The time to maximal sugar level during an oral glucose tolerance test is associated with higher risk for prediabetes and could give important information about…

Alcohol Abuse Even Before Pregnancy May Harm Offspring
April 2, 2017 | Mothers who binge drink before they become pregnant may be more likely to have children with high blood sugar and other changes in glucose function…

Late Sleep-Wake Time Preference Linked to Depression in Individuals with Diabetes
April 1, 2017 | People with type 2 diabetes who are “night owls” and prefer the evening for activity report having more symptoms of depression than those who are early to bed…

Explore highlights of current education across the Endocrine Society.

New Drugs in Diabetes – the Great Debate: How to Treat Type 2 Diabetes?
ENDO Session | No credit available
Faculty: David Nathan, MD and Daniel Drucker, MD
One of the most talked about sessions at ENDO 2017 was this much-anticipated debate. David Nathan, MD asks Are We Benefitting Anyone Other Than Pharma? while Daniel Drucker, MD sees True Innovation with Real Patient Benefits…

Can We Improve Cardiovascular Risk in Type 2 Diabetes?
ENDO Session | No credit available
Faculty: Cecilia C. Low Wang MD; Matthew Cavender, MD, MPH; Jennifer Green, MD; and William T. Cefalu, MD
Hear the latest about underlying mechanisms of cardiovascular disease and the impact of diabetes therapies in patients with diabetes.

Type 2 Diabetes Management in Patients with Cardiovascular Disease Risk
Beta Cells in Diabetes Case Study | 0.5 AMA PRA Category 1 Credit™
Faculty: Doron Schneider, MD and Bernard Zinman, MD
Follow this case study about Roberta, a 62-year-old African American secretary with type 2 diabetes, and hear insights on options to reduce cardiovascular risk.

Diabetes Diagnosis & Management 2017
Workshop Webcast | 7.5 AMA PRA Category 1 Credit™ and ABIM MOC Part 2 points
Planning Chairs: Johns (Jack) L. Leahy, MD and Carol H. Wysham, MD
Expert faculty provide state-of-the-art updates on cardiometabolic co-morbidities, new treatment options, and day-to-day strategies to manage patients with diabetes.

Best Practices for Type 2 Diabetes Management
Webcast | 1.0 AMA PRA Category 1 Credit™
Vivian A. Fonseca, MD, FRCP
Learn the best practices for the management of type 2 diabetes based on the latest guidelines and emerging treatment approaches.

New Options and Combinations in Diabetes Management: Optimizing Control and Individualizing Treatment
ENDO Satellite Symposium | 2.0 AMA PRA Category 1 Credits™
Chair: Anne L. Peters, MD
Faculty: Carol H. Wysham, MD; David M. Kayne, MD; and Janet B. McGill, MD
Use new options in GLP-1 receptor agonists, basal insulins, and combinations therein to improve patient outcomes.

Trial Updates in Type 2 Diabetes
CEU Satellite Symposium | 1.0 AMA PRA Category 1 Credit™
Carol H. Wysham, MD
Summarize cardiovascular complications and risk factors and integrate updated knowledge into practice, including the latest from the EMPA-REG and LEADER trials.

Diabetes @Point of Care
Practice Resource | Credit available
Find practical information when you need it the most to recognize signs, interpret results, and guide treatment decisions.

Epigenetic Changes in Patients with Type 2 Diabetes and Impact on Insulin Secretion and Action
ENDO Session | No credit available
Charlotte Ling, PhD
Learn about recent discoveries in potential epigenetic contributions to the development and progression of type 2 diabetes.

Transitions of Care: Type 1 Diabetes
Practice Resource | No credit available
Find resources for you and your patients to facilitate the challenging transition from pediatric to adult endocrine practice.

Endocrine Fellows Series: Type 1 Diabetes Care and Management 2016
Fellows Workshop Webcast | 15.0 AMA PRA Category 1 Credits™
Program Directors: Irl B. Hirsch, MD and Linda Siminerio, PhD
Engage in a comprehensive program for pediatric and adult endocrine fellows including foundation education, practice management strategies, and practical approaches to challenging cases.

Endocrine Facts & Figures: Diabetes
Research Resource | No credit available
Advisory Panel Chair: Robert A. Vigersky, MD
Updated epidemiological data and in-depth discussion on the common types of diabetes and related conditions with current citations and expert insights.

Explore highlights of current publications across the Endocrine Society journals. Visit academic.oup.com/endocrinesociety for more.

The Relationship Between Thyroid Function and the Prevalence of Type 2 Diabetes Mellitus in Euthyroid Subjects
JCEM | December 01, 2016
Yeqing Gu, Huihui Li, Xue Bao, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Huanmin Du, Hongbin Shi, Yang Xia, Qian Su, Liyun Fang, Fei Yu, Huijun Yang, Bin Yu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Qi Guo, Hong Chang, Guolin Wang, Guowei Huang, Kun Song, and Kaijun Niu
Type 2 diabetes mellitus (T2DM) is the most common chronic endocrine disease, characterized by hyperglycemia resulting from impaired insulin secretion…

Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study
JCEM | November 23, 2016
Emma Hamilton, Wendy A. Davis, David G. Bruce, and Timothy M. E. Davis
There is consistent evidence that type 2 diabetes is associated with an increased incidence of hip fracture, with a relative risk in meta-analyses of between…

Mortality Among Hospitalized Patients With Hypoglycemia: Insulin Related and Noninsulin Related
JCEM | November 17, 2016
Amit Akirov, Alon Grossman, Tzipora Shochat, and Ilan Shimon
Spontaneous and insulin-related hypoglycemia is common among hospitalized patients with and without diabetes mellitus (DM)…

Effect of Soy in Men With Type 2 Diabetes Mellitus and Subclinical Hypogonadism: A Randomized Controlled Study
JCEM | October 31, 2016
Thozhukat Sathyapalan, Alan S. Rigby, Shalender Bhasin, Natalie J. Thatcher, Eric S. Kilpatrick, and Stephen L. Atkin
Production and consumption of soy foods within Western countries have increased dramatically in the past decade, with the postulated health benefits including…

Diagnosis of ABCC8 Congenital Hyperinsulinism of Infancy in a 20-Year-Old Man Evaluated for Factitious Hypoglycemia
JCEM | October 18, 2016
Amichai Gutgold, David J. Gross, Benjamin Glaser, and Auryan Szalat
A 20-year-old male military paramedic was referred to our emergency department for evaluation of recurrent hypoglycemia episodes. One day before presenting to our hospital…

Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study
JCEM | October 12, 2016
Jean-Michel Petit, Jean-Pierre Cercueil, Romaric Loffroy, Damien Denimal, Benjamin Bouillet, Coralie Fourmont, Olivier Chevallier, Laurence Duvillard, and Bruno Vergès
Nonalcoholic fatty liver disease (NAFLD) is commonly associated with type 2 diabetes and increases the risk for the development of nonalcoholic steatohepatitis (NASH), cirrhosis, and…

Autoimmune Diseases in Children and Adults with Type 1 Diabetes from the T1D Exchange Clinic Registry
JCEM | September 27, 2016
Jing W. Hughes, Tonya D. Riddlesworth, Linda A. DiMeglio, Kellee M. Miller, Michael R. Rickels, and Janet B. McGill
Type 1 diabetes (T1D) is associated with other autoimmune diseases (AIDs), but the prevalence and associated predictive factors for these comorbidities of T1D across all age groups have not been…

Spontaneous Hypoglycemia after Islet Transplantation: The Case for Using Non-Hepatic Sites
JCEM | September 9, 2016
R. Paul Robertson
This Perspective provides a brief history of intrahepatic alloislet and autoislet transplantation in humans and an update of the recent success rates. It also examines the important role that…

Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans
JCEM | September 7, 2016
Ron T. Varghese, Chiara Dalla Man, Anu Sharma, Ivan Viegas, Cristina Barosa, Catia Marques, Meera Shah, John M. Miles, Robert A. Rizza, John G. Jones, Claudio Cobelli, and Adrian Vella
Prediabetes is a heterogeneous disorder classified on the basis of fasting glucose concentrations and 2-hour glucose tolerance. We sought to determine the relative contributions of insulin secretion…

Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes
JCEM | August 26, 2016
Michael R. Rickels, Amy J. Peleckis, Eileen Markmann, Cornelia Dalton-Bakes, Stephanie M. Kong, Karen L. Teff, and Ali Najibr
Hypoglycemia is a major barrier to the achievement of adequate glycemic control for most patients with type 1 diabetes (T1D). The American Diabetes Association treatment guidelines recommend that adults with T1D target glycosylated hemoglobin (HbA1c) levels <7.0% unless…

For a complete list of Endocrine Society guidelines, visit endocrine.org/guidelines.

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults
JCEM | September 2, 2016
Anne L. Peters(chair), Andrew J. Ahmann, Tadej Battelino, Alison Evert, Irl B. Hirsch, M. Hassan Murad, William E. Winter, and Howard Wolpert
Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of…

Diabetes and Pregnancy
JCEM | December 4, 2013
Ian Blumer, Eran Hadar, David R. Hadden, Lois Jovanovič, Jorge H. Mestman, M. Hassan Murad, and Yariv Yogev
Using an evidence-based approach, this Diabetes and Pregnancy Clinical Practice Guideline addresses important clinical issues in the contemporary management of women with type 1 or type 2 diabetes…

Management of Hyperglycemia in Hospitalized Patients in Non-critical Care Setting
JCEM | July 2, 2013
Guillermo E. Umpierrez, Richard Hellman, Mary T. Korytkowski, Mikhail Kosiborod, Gregory A. Maynard, Victor M. Montori, Jane J. Seley, and Greet Van den Berghe
Hyperglycemia is a common, serious, and costly health care problem in hospitalized patients. Observational and randomized controlled studies indicate that improvement in glycemic control results…

Evaluation and Management of Adult Hypoglycemic Disorders
JCEM | April 30, 2011
Philip E. Cryer, Lloyd Axelrod, Ashley B. Grossman, Simon R. Heller, Victor M. Montori, Elizabeth R. Seaquist, and F. John Service
We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad--symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and…

Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk
JCEM | January 14, 2009
James L. Rosenzweig, Ele Ferrannini, Scott M. Grundy, Steven M. Haffner, Robert J. Heine, Edward S. Horton, and Ryuzo Kawamori
Healthcare providers should incorporate into their practice concrete measures to reduce the risk of developing CVD and T2DM. These include the regular screening and identification of patients at…

For additional meetings, visit the Endocrine Society’s Worldwide Endocrinology Calendar at endocrine.org/calendar.

Dimensions in Diabetes
Dates: June 17-18, 2017
Sponsor: Endocrine Society
Location: Mumbai, India

19th Asia Pacific Diabetes Conference
Dates: July 20-22, 2017
Sponsor: Conference series LLC
Location: Melbourne, Victoria, Australia

Clinical Endocrinology Update & Endocrine Board Review
Dates: September 23–27, 2017
Location: Chicago, Illinois, United States
Sponsor: Endocrine Society
Whether you need the latest clinical information or you’re preparing to certify or recertify for the boards, Clinical Endocrinology Update (CEU) and Endocrine Board Review (EBR) have you covered.

22nd International Congress on Prevention of Diabetes and Complications
Dates: October 12-13, 2017
Sponsor: Conference series LLC
Location: London, England, United Kingdom

ENDO 2018
Dates: March 17–20, 2018
Location: Chicago, Illinois, United States
Sponsor: Endocrine Society
ENDO is the world’s largest event for presenting and obtaining the latest in endocrine science and medicine with an extensive program covering a broad array of topics, various networking opportunities, poster sessions, updates on new products and technologies at the ENDOExpo, and more.